Delayed growth and puberty in patients with Gaucher disease type 1: Natural history and effect of splenectomy and/or enzyme replacement therapy

Israel Medical Association Journal

Volumn 2, Issue 2, 2000, Pages 158-163

  Kauli, R ^a   Zaizov, R ^a   Lazar, L ^a   Pertzelan, A ^a   Laron, Z ^a   Galatzer, A ^a   Phillip, M ^a   Yaniv, Y ^a   Cohen, I J ^a  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

Author keywords

Enzyme replacement therapy; Final height; Gaucher disease type 1; Growth; Puberty; Splenectomy

Indexed keywords

ALGLUCERASE; GLUCOSYLCERAMIDASE; IMIGLUCERASE;

ADOLESCENT; ADULT; ARTICLE; BODY HEIGHT; CATCH UP GROWTH; CHILD; DELAYED PUBERTY; DISEASE SEVERITY; DOSE RESPONSE; ENZYME REPLACEMENT; FEMALE; GAUCHER DISEASE; GENE MUTATION; GENOTYPE; GROWTH RETARDATION; HORMONE DETERMINATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCYTOPENIA; SEXUAL MATURATION; SPLENECTOMY;

ADOLESCENT; ADULT; ANALYSIS OF VARIANCE; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GAUCHER DISEASE; GENOTYPE; GLUCOSYLCERAMIDASE; GROWTH DISORDERS; HUMANS; ISRAEL; JEWS; MALE; PUBERTY, DELAYED; RECOMBINANT PROTEINS; SEVERITY OF ILLNESS INDEX; SPLENECTOMY;

EID: 0033843490     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Gaucher disease, clinical laboratory, radiologic and genetic features of 53 patients
2. Growth and growth hormone
3. Normal and abnormal growth
4. Puberty: Ontogeny, neuroendocrinology, physiology, and disorders
5. Delayed puberty and hypogonadism
6. Chronic Gaucher disease
7. Adult-type Gaucher disease in children: Genetics, clinical features and enzyme replacement therapy
8. Growth and development in children with Type I Gaucher disease
9. Growth in children with Type I Gaucher disease, treated with Ceredase
10. Acceleration of retarded growth in children with Gaucher disease after treatment with alglucerase
11. A practical approach to diagnosis and management of Gaucher disease
12. Long follow-up of partial splenectomy in Gaucher's disease
13. Lower-dose, high-frequency enzyme replacement therapy in children with Gaucher disease type I. Experience at the Schneider Children's Medical Center of Israel
14. Standards from birth to maturity for height, weight, height velocity and weight velocity: British Children 1965, part II
15. Standards for children's height at ages 2-9 years allowing for height of parents
16. Insulin-like growth factor I (IGF-I) in healthy children, adolescents and adults as determined by a radioimmunoassay specific for the synthetic 52-70 peptide region
17. Resting energy expenditure in Gaucher's disease type 1: Effect of Gaucher's cell burden on energy requirements
18. Increased basal glucose production in type 1 Gaucher's disease
19. Differential effects of enzyme supplementation therapy on manifestations of type 1 Gaucher disease
20. Normal and aberrant growth
21. Outcome of partial splenectomy for type I Gaucher disease